Recent studies for staging of lung cancer with EBUS-TBNA
The diagnosis of sarcoidosis is based on clinico-radiological findings and histological evidence of non-caseating epithelioid-cell granulomas . Traditionally, if pulmonary sarcoidosis is suspected, pathological diagnostic materials are often obtained using conventional bronchoscopy together with procedures such as bronchoalveolar lavage (BAL) for evaluation of disease activity, transbronchial needle aspiration (TBNA) for hilar/mediastinal lymph node lesions, transbronchial lung biopsy (TBLB) for lung parenchymal lesions, and transbronchial biopsy (TBB) for endobronchial lesions. In most cases, however, definitive pathological diagnosis of this disease mainly depends on TBLB for lung parenchymal lesions because hilar/mediastinal lymph node lesions are often difficult to access and endobronchial lesions are uncommon. The diagnostic yield of TBLB in this disease is reportedly about 40–90% when several biopsy samples are obtained [2, 3]. When mediastinal or hilar lymphadenopathy is detected on computed tomography (CT) and cannot be diagnosed with conventional bronchoscopy, mediastinoscopy is performed to obtain histological samples. Although the diagnostic sensitivity of this procedures is >90% [4, 5], it is invasive and requires general anesthesia . In this chapter, a newly developed bronchoscopic technique, endobronchial ultrasonography (EBUS)-guided transbronchial needle aspiration (EBUS-TBNA) for the definitive diagnosis of sarcoidosis is discussed.
2. EBUS-TBNA, a newly developed bronchoscopic technique
An endobronchial ultrasound, recently developed in Japan [6, 7], is a bronchoscope equipped with a convex-type ultrasound probe at the tip of the scope to simultaneously visualize endobronchial images with optical-wavelength light and images of peribronchial structures, such as lymph nodes and vessels, with ultrasound (Figure 1). By introducing a specialized TBNA needle into the forceps channel, it is possible to obtain cytological and even histological samples [6, 7]. This technique was developed primarily as a novel minimally invasive diagnostic technique for lymph node staging of lung cancer [6, 8- 17]. As summarized in Table 1, initial research disclosed its high sensitivity and diagnostic yields for this purpose. This new technique has obviated the need for classical and invasive mediastinoscopy in many cases, and a current European guideline for lymph node staging in lung cancer primarily recommends EBUS-TBNA over mediastinoscopy . Recent reports also indicate that EBUS-TBNA is a valuable diagnostic method for pulmonary sarcoidosis with hilar/mediastinal lymphadenopathy [19 - 32]. The presence of non-caseating epithelioid-cell granulomas in the lymph nodes obtained by EBUS-TBNA suggests the diagnosis of granulomatous disease including sarcoidosis.
3. Technique to obtain histological and cytological materials with EBUS-TBNA
EBUS-TBNA is performed under local anesthesia with mild sedation, which is comparable to conventional bronchoscopy [7 - 11]. Contrast medium-enhanced CT images are used to identify target lymph nodes. A convex-probe-equipped EBUS bronchoscope (CP-EBUS; for example, BF-UC260F-OL8; Olympus, Tokyo, Japan) supported by an ultrasound image processor (model EU-C2000; Olympus) and a dedicated 22- or 21-gauge aspiration needle (NA-201SX-4022/NA-201SX-4021; Olympus) are used (Figures 2, 3). Although 21 G and 22 G needles yield similar sensitivity in the diagnosis of malignant diseases, 22 G needles are more efficient than 21 G needles for obtaining materials from patients with sarcoidosis . While the target lymph node is visualized with EBUS, a transbronchial puncture under real-time ultrasound guidance is performed with a needle equipped with an internal sheath (Figure 4). The internal sheath prevents clogging of the needle with bronchial epithelial cells. On confirming that the tip of the needle has penetrated the target lymph node, the internal sheath is removed, and rapid negative pressure is applied by aspirating with a 20-mL syringe several times. After the needle is moved back and forth inside the lymph node under real-time ultrasound guidance, it is retrieved and the internal sheath is used to expel the material aspirated in the needle (Figure 5). A histological core is first obtained in many cases; this material is placed on a small piece of filter paper for fixation in 10% buffered formalin. The internal sheath is then removed, and positive pressure is applied using an air-filled 20-mL syringe to expel the remaining material in the needle onto a glass slide, which is then smeared against another glass slide by using the squash preparation technique to yield cytological smears on 2 glass slides (Figure 6). Both histological cores and cytological specimens are obtained in many cases with this method. In our institution, tentative on-site cytological diagnosis by a cytoscreener is available. One of the cytological slides is placed in 95% ethanol for fixation and staining with the Papanicolaou technique. The other one is air-dried, stained with a Romanowsky-type stain (Diff-Quik®), and sent for on-site evaluation. The cytoscreener ensures that the specimen is of adequate quality. Tissue sampling is repeated until sufficient material is obtained. The aspirated materials can also be dispersed into sterile saline solution for microbiological examinations, including staining and culture for bacteria, fungi, and acid-fast bacilli. In addition, polymerase chain reaction examinations can be performed for acid-fast bacilli. Histological diagnoses are based on the results of hematoxylin and eosin (H-E) staining.
BAL followed by TBLB with conventional bronchoscopy is performed before EBUS-TBNA [22,28] when required.
4. Sensitivity and specificity of EBUS-TBNA in the diagnosis of sarcoidosis
Table 2 summarizes the results of recent reports and shows a diagnostic sensitivity for sarcoidosis of EBUS-TBNA ranging from 56% to 94% [19 - 32]. Non-caseating epithelioid-cell granulomas on histological examination of EBUS-TBNA specimens have high sensitivity and specificity for sarcoidosis at stages 1 and 2. Nakajima et al. , Oki et al. , and Kitamura et al.  reported that the sensitivity of EBUS-TBNA for stage 1 and 2 sarcoidosis is much higher than that of TBLB from the lung parenchyma.
5. Diagnostic validity for sarcoidosis of epithelioid-cell clusters on cytological examination
Cytological evaluation has been reported in the diagnosis of sarcoidosis with conventional TBNA, trans-esophageal ultrasound-guided biopsy [34 - 40], and EBUS-TBNA [41,42]; however, the validity of the diagnostic criteria has not been defined.
Epithelioid-cell clusters suggesting the presence of granulomas are defined by variably-sized loose collections of non-pigmented epithelioid or spindle-cell histiocytes that are usually accompanied by lymphocytes . Typical cytological findings are shown in Figures 7 to 10, together with their corresponding histological findings obtained from the same aspiration. The validity of cytological evaluation in the diagnosis of sarcoidosis, however, was not well-defined. To elucidate the diagnostic validity of epithelioid-cell clusters on cytological examination, we performed a study in which cytological samples from 72 patients with sarcoidosis and 116 control patients with malignant lung diseases mainly of primary lung cancer (with lymphadenopathy eventually proven to be metastasis free) were evaluated independently by 2 cytoscreeners and a pathologist, all blinded to patient information. The results included excellent inter-observer variability and a high specificity of 94.0%, indicating validity of cytological diagnosis of sarcoidosis . Our study also uncovered a very high rate (87.5% or 63/72) of pathological proof of epithelioid-cell granulomas when cytological and histological evaluations with EBUS-TBNA-obtained materials were combined. Validity of cytological diagnosis of sarcoidosis might be applicable to other organs.
6. Epithelioid-cell granulomas in lymphadenopathy with lung cancer
Non-caseating epithelioid-cell granulomas may be seen in draining lymph nodes in various malignant diseases. These relatively uncommon histological findings, which are not systemic sarcoidosis, have been termed sarcoid reactions . Sarcoid reactions are also seen in lung malignancy with a reported incidence of 1.2–4.3% [44- 46]. This value was 6.0% in our study , that is, cytological evaluation of the EBUS-TBNA samples revealed epithelioid-cell clusters in lymph nodes from 7 patients out of the 116 patients with primary lung cancer whose lymphadenopathy was eventually proven to be metastasis free. Sarcoid reactions probably reflect an immune response to tumor antigens due to T-cell mediated immune responses . The tumor antigens are thought to be carried by lymphatic vessels to the draining lymph nodes, causing sarcoid reactions in situ . Although uncommon, it is very important that this is considered in the pathological diagnosis of sarcoidosis. There is no report on differentiating sarcoidosis from sarcoid reactions on the basis of histological and/or cytological findings. Clinical differentiation of sarcoid reaction from sarcoidosis, however, may not be difficult because of the presence of primary lesion and asymmetric distribution of the hilar/mediastinum lymphadenopathy. Nevertheless, it should be stressed that sarcoid reaction potentially misleads N staging of the lung cancer.
7. Future directions
As discussed in the above sections, EBUS-TBNA results in a very high rate (>80%) of pathological proof of sarcoidosis provided enlarged hilar/mediastinal lymph nodes are accessible. The technique has been reported to be very safe because target lymph nodes and surrounding vessels are easily visualized with ultrasound images. In contrast, the sensitivity of TBLB of pulmonary parenchymal lesions is reportedly much lower than that with EBUS-TBNA. In fact, it was 34.5% (or 20/58) in our study , where only 58 patients out of the 72 patients with sarcoidosis were evaluated with TBLB because of absent pulmonary lesions in the imaging studies and/or possible complications. TBLB is potentially invasive; consequently, the procedure may be complicated with massive bleeding or pneumothorax. These possible complications may justify avoiding TBLB in the diagnosis of sarcoidosis when EBUS-TBNA is available. Excluding certain conditions where proof of pulmonary parenchymal lesions is required, prioritizing EBUS-TBNA over TBLB would be reasonable. Advances in this new technology might change the diagnostic practices in sarcoidosis.
In addition, easier access to involved lymph nodes with EBUS-TBNA may provide new opportunities to obtain biomarkers for elucidating pathogenesis of the disease. In fact, Nakajima et al.  and Sakairi et al.  were successful with this technique in detecting various gene mutations in patients with lung cancer. Similar advances with the same technique in the field of sarcoidosis and other granulomatous diseases would be realistic. We anticipate that sarcoidosis, an unpleasant refractory disease, will be conquered by applied investigation and personalized care in the future.
Statement on sarcoidosisJoint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 160 736 755
Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis Gilman M. J Wang K. P 1980 122 721 724
Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax De Boer S Milne D. G Zeng I et al 2009 64 436 439
Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med Raghu G 1995 151 909 914
Mediastinoscopy vs thoracoscopy for mediastinal biopsy. Results of a prospective nonrandomized study. Chest Gossot D Toledo L Fritsch S et al 1996 110 1328 1331
Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer Yasufuku K Chiyo M Koh E et al 2005 50 347 354
Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest Yasufuku K Chiyo M Sekine Y et al 2004 126 122 128
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer Gu P Zhao Y. Z Jiang L. Y et al 2009 45 1389 1396
Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax Adams K Shah P. L Edmonds L et al 2009 64 757 762
Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest Yasufuku K Nakajima T Motoori K et al 2006 130 710 718
Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J Herth F. J Ernst A Eberhardt R et al 2006 28 910 914
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg El- Vincent B. D Bayoumi E Hoffman B et al 2008 85 224 230
Minimally invasive endoscopic staging of suspected lung cancer. JAMA Wallace M. B Pascual J. M Raimondo M et al 2008 299 540 546
Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest Herth F. J Eberhardt R Krasnik M et al 2008 133 887 891
Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol Ernst A Anantham D Eberhardt R et al 2008 3 577 582
Omark Petersen HEckardt J, Hakami A, et al. The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer. Eur J Cardiothorac Surg 2009 36 465 468
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg Yasufuku K Pierre A Darling G et al 2011 142 1393 1400e1391
European trends in preoperative and intraoperative nodal staging: ESTS guidelines. J Thorac Oncol De Leyn P Lardinois D Van Schil P et al 2007 2 357 361
Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest Garwood S Judson M. A Silvestri G et al 2007 132 1298 1304
Real-time endobronchial ultrasound-guided transbronchial needle aspiration is useful for diagnosing sarcoidosis. Respirology Oki M Saka H Kitagawa C et al 2007 12 863 868
Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J Wong M Yasufuku K Nakajima T et al 2007 29 1182 1186
The role of EBUS-TBNA for the diagnosis of sarcoidosis--comparisons with other bronchoscopic diagnostic modalities. Respir Med Nakajima T Yasufuku K Kurosu K et al 2009 103 1796 1800
A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest Tremblay A Stather D. R Maceachern P et al 2009 136 340 346
Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnostics fail. Sarcoidosis Vasc Diffuse Lung Dis Eckardt J Olsen K. E Jorgensen O. D et al 2010 27 43 48
The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis. Eur Respir J Tournoy K. G Bolly A Aerts J. G et al 2010 35 1329 1335
Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. Respirology Navani N Booth H. L Kocjan G et al 2011 16 467 472
Da Costa J, et al. The Diagnostic Utility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Compared to Transbronchial and Endobronchial Biopsy for Suspected Sarcoidosis. Intern Med J Plit M Pearson R 2012 42 434 438
Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis. J Thorac Cardiovasc Surg Oki M Saka H Kitagawa C et al 2012 143 1324 1329
Feasibility of cytological diagnosis of sarcoidosis with endobronchial US-guided transbronchial aspiration. Sarcoidosis Vasc Diffuse Lung Dis Kitamura A Takiguchi Y Kurosu K et al 2012in press)
Ultrasound endoscopy (EBUS, EUS) as a sophisticated tool for morphological confirmation of sarcoidosis: do we need to find new answers for an old quest? Sarcoidosis Vasc Diffuse Lung Dis Poletti V Tomassetti S 2010 27 5 6
Endobronchial ultrasound-guided transbronchial needle aspiration cytology: a state of the art review. Cytopathology Cameron S. E Andrade R. S Pambuccian S. E 2010 21 6 26
Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: A systematic review and meta-analysis. Respir Med Agarwal R Srinivasan A Aggarwal A. N et al 2012 106 883 892
Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration. Respirology Nakajima T Yasufuku K Takahashi R et al 2011 16 90 94
The clinical application and cost analysis of fine-needle aspiration biopsy in the diagnosis of mass lesions in sarcoidosis. Chest Tambouret R Geisinger K. R Powers C. N et al 2000 117 1004 1011
Transbronchial needle aspiration in sarcoidosis: yield and predictors of a positive aspirate. J Thorac Cardiovasc Surg Trisolini R Tinelli C Cancellieri A et al 2008 135 837 842
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA Annema J. T Van Meerbeeck J. P Rintoul R. C et al 2010 304 2245 2252
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Endoscopy Von Bartheld M. B Veselic-charvat M Rabe K. F et al 2010 42 213 217
The yield of endoscopic ultrasound-guided fine needle aspiration for histological diagnosis in patients suspected of stage I sarcoidosis. Endoscopy Iwashita T Yasuda I Doi S et al 2008 40 400 405
Diagnostic value of transbronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest Cetinkaya E Yildiz P Altin S et al 2004 125 527 531
The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest Trisolini R Agli L. L Cancellieri A et al 2003 124 2126 2130
Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer Cytopathol Feller-kopman D Yung R. C Burroughs F et al 2009 117 482 490
Cytologic accuracy of samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration at Thomas Jefferson University Hospital. Acta Cytol Jacob-ampuero M. P Haas A. R Ciocca V et al 2008 52 687 690
Sarcoid reactions in malignant tumours. Cancer Treat Rev Brincker H 1986 13 147 156
Sarcoidal reactions in regional lymph nodes of patients with non-small cell lung cancer: incidence and implications for minimally invasive staging with endobronchial ultrasound. Lung Cancer Steinfort D. P Irving L. B 2009 66 305 308
Kennedy MP, Jimenez CA, Mhatre AD, et al. Clinical implications of granulomatous inflammation detected by endobronchial ultrasound transbronchial needle aspiration in patients with suspected cancer recurrence in the mediastinum. J Cardiothorac Surg 2008; 3:8
Surgical results of lung cancer with sarcoid reaction in regional lymph nodes. Jpn J Clin Oncol Tomimaru Y Higashiyama M Okami J et al 2007 37 90 95
Inflammatory cells in the formation of tumor-related sarcoid reactions. Hum Pathol Kurata A Terado Y Schulz A et al 2005 36 546 554
Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest Nakajima T Yasufuku K Nakagawara A et al 2011 140 1319 1324
EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res Sakairi Y Nakajima T Yasufuku K et al 2010 16 4938 4945